Application of (212)Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.
about
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models.212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models.Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC.
P2860
Application of (212)Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Application of (212)Pb for Tar ...... rough to Clinical Translation.
@ast
Application of (212)Pb for Tar ...... rough to Clinical Translation.
@en
type
label
Application of (212)Pb for Tar ...... rough to Clinical Translation.
@ast
Application of (212)Pb for Tar ...... rough to Clinical Translation.
@en
prefLabel
Application of (212)Pb for Tar ...... rough to Clinical Translation.
@ast
Application of (212)Pb for Tar ...... rough to Clinical Translation.
@en
P2860
P1433
P1476
Application of (212)Pb for Tar ...... rough to Clinical Translation.
@en
P2093
Martin Brechbiel
P2860
P304
P356
10.3934/MEDSCI.2015.3.228
P577
2015-08-18T00:00:00Z